Skip to main content

Is My Product Recalled?

Food Recalls Medication Recalls Baby Products Pet Products Toys Electronics Household Vehicles Medical Devices Other

Scan How It Works Saved Get Alerts

Menu

Search All Recalls Latest Recalls Scan Barcode Get Alerts

Categories

Food Recalls Medication Recalls Baby Products Pet Products Toys Electronics Household Vehicles Medical Devices Other

Resources

How Recalls Work FAQ Recall Classifications Statistics & Trends About

Your Recalls

Loading...

Stay Informed

Get email alerts when new recalls match your interests.

Recall data is updated hourly from official government sources. Very recent recalls may not yet appear. About our data sources

About

We make U.S. recall data searchable and accessible for consumers and businesses.

Site

FAQ
Browse by State
Statistics
Recall Classifications
About
Enterprise API

Legal

Privacy Policy
Terms of Service
Report Incorrect Info

Official Sources

FDA Recalls ↗
USDA FSIS ↗
CPSC Recalls ↗
NHTSA Recalls ↗

Home
/
Brands
/
Olympia Compounding Pharmacy dba Olympia Pharmacy

Olympia Compounding Pharmacy dba Olympia Pharmacy Recalls

All product recalls associated with Olympia Compounding Pharmacy dba Olympia Pharmacy.

Get alerts for this brand

Recall Summary

Total Recalls

1000

Past Year

433

Class I (Serious)

138

Most Recent

Dec 2025

Data from FDA, USDA, CPSC, and NHTSA public records. Recall counts vary by company size, industry, and reporting practices. Always check official sources for current information.

Showing 1941–1960 of 7663 recalls

Ultratest Testosterone (Olympia Pharmacy) – CGMP Monitoring Issues (2022)

CGMP Deviations: prior to October 1, 2021, environmental and personnel monitoring Out of Action Limit (OOAL) excursions were not being properly investigated

Class IIModerate

FDAApr 4, 2022Nationwide• Olympia Compounding Pharmacy dba Olympia Pharmacy

RE-1 Medication (Olympia Pharmacy) – CGMP Monitoring Issues (2022)

CGMP Deviations: prior to October 1, 2021, environmental and personnel monitoring Out of Action Limit (OOAL) excursions were not being properly investigated

Class IIModerate

FDAApr 4, 2022Nationwide• Olympia Compounding Pharmacy dba Olympia Pharmacy

QM-4 Medication (Olympia Pharmacy) – CGMP Monitoring Issues (2022)

1...96 979899 100...384

Page 98 of 384Next

CGMP Deviations: prior to October 1, 2021, environmental and personnel monitoring Out of Action Limit (OOAL) excursions were not being properly investigated

Class IIModerate

FDAApr 4, 2022Nationwide• Olympia Compounding Pharmacy dba Olympia Pharmacy

Formula F2 (Olympia Pharmacy) – CGMP Monitoring Issues (2022)

CGMP Deviations: prior to October 1, 2021, environmental and personnel monitoring Out of Action Limit (OOAL) excursions were not being properly investigated

Class IIModerate

FDAApr 4, 2022Nationwide• Olympia Compounding Pharmacy dba Olympia Pharmacy

RE-2 Medication (Olympia Pharmacy) – CGMP Monitoring Issues (2022)

CGMP Deviations: prior to October 1, 2021, environmental and personnel monitoring Out of Action Limit (OOAL) excursions were not being properly investigated

Class IIModerate

FDAApr 4, 2022Nationwide• Olympia Compounding Pharmacy dba Olympia Pharmacy

ST-2 Medication (Olympia Pharmacy) – CGMP Monitoring Issues (2022)

CGMP Deviations: prior to October 1, 2021, environmental and personnel monitoring Out of Action Limit (OOAL) excursions were not being properly investigated

Class IIModerate

FDAApr 4, 2022Nationwide• Olympia Compounding Pharmacy dba Olympia Pharmacy

SB-5 Papaverine Phentolamine (Olympia) - CGMP Monitoring Issues (2022)

CGMP Deviations: prior to October 1, 2021, environmental and personnel monitoring Out of Action Limit (OOAL) excursions were not being properly investigated

Class IIModerate

FDAApr 4, 2022Nationwide• Olympia Compounding Pharmacy dba Olympia Pharmacy

QM-3 Papaverine Phentolamine (Olympia) - CGMP Monitoring Issues (2022)

CGMP Deviations: prior to October 1, 2021, environmental and personnel monitoring Out of Action Limit (OOAL) excursions were not being properly investigated

Class IIModerate

FDAApr 4, 2022Nationwide• Olympia Compounding Pharmacy dba Olympia Pharmacy

FA Papaverine Phentolamine (Olympia) - CGMP Monitoring Issues (2022)

CGMP Deviations: prior to October 1, 2021, environmental and personnel monitoring Out of Action Limit (OOAL) excursions were not being properly investigated

Class IIModerate

FDAApr 4, 2022Nationwide• Olympia Compounding Pharmacy dba Olympia Pharmacy

Sincalide Lyophilized Powder (Olympia) - CGMP Monitoring Issues (2022)

CGMP Deviations: prior to October 1, 2021, environmental and personnel monitoring Out of Action Limit (OOAL) excursions were not being properly investigated

Class IIModerate

FDAApr 4, 2022Nationwide• Olympia Compounding Pharmacy dba Olympia Pharmacy

SB-4 Papaverine Phentolamine (Olympia) - CGMP Monitoring Issues (2022)

CGMP Deviations: prior to October 1, 2021, environmental and personnel monitoring Out of Action Limit (OOAL) excursions were not being properly investigated

Class IIModerate

FDAApr 4, 2022Nationwide• Olympia Compounding Pharmacy dba Olympia Pharmacy

T-106 Papaverine Phentolamine (Olympia) - CGMP Monitoring Issues (2022)

CGMP Deviations: prior to October 1, 2021, environmental and personnel monitoring Out of Action Limit (OOAL) excursions were not being properly investigated

Class IIModerate

FDAApr 4, 2022Nationwide• Olympia Compounding Pharmacy dba Olympia Pharmacy

Sermorelin Acetate (Olympia) - CGMP Monitoring Issues (2022)

CGMP Deviations: prior to October 1, 2021, environmental and personnel monitoring Out of Action Limit (OOAL) excursions were not being properly investigated

Class IIModerate

FDAApr 4, 2022Nationwide• Olympia Compounding Pharmacy dba Olympia Pharmacy

Diluent Reconstitution Solution (Olympia) - CGMP Monitoring Issues (2022)

CGMP Deviations: prior to October 1, 2021, environmental and personnel monitoring Out of Action Limit (OOAL) excursions were not being properly investigated

Class IIModerate

FDAApr 4, 2022Nationwide• Olympia Compounding Pharmacy dba Olympia Pharmacy

AT-6 Papaverine Phentolamine (Olympia) - CGMP Monitoring Issues (2022)

CGMP Deviations: prior to October 1, 2021, environmental and personnel monitoring Out of Action Limit (OOAL) excursions were not being properly investigated

Class IIModerate

FDAApr 4, 2022Nationwide• Olympia Compounding Pharmacy dba Olympia Pharmacy

Testosterone Cypionate (Olympia) - CGMP Monitoring Issues (2022)

CGMP Deviations: prior to October 1, 2021, environmental and personnel monitoring Out of Action Limit (OOAL) excursions were not being properly investigated

Class IIModerate

FDAApr 4, 2022Nationwide• Olympia Compounding Pharmacy dba Olympia Pharmacy

PGE-3 Alprostadil (Olympia Pharmacy) – CGMP Monitoring Issues (2022)

CGMP Deviations: prior to October 1, 2021, environmental and personnel monitoring Out of Action Limit (OOAL) excursions were not being properly investigated

Class IIModerate

FDAApr 4, 2022Nationwide• Olympia Compounding Pharmacy dba Olympia Pharmacy

Mercedes-Benz S 500 (Mercedes-Benz) – steering column issue (2022)

Mercedes-Benz USA, LLC (MBUSA) is recalling certain 2021 S580 4Matic and S500 4Matic vehicles. The electrical connector to the steering column module may not be secured properly, which can disable gear shifts and/or safety features including the electronic stability program, the driver's air bag, and turn signal indicators.

NHTSAApr 1, 2022Nationwide• MERCEDES-BENZ

Esomeprazole Magnesium Capsules (Mylan) – Impurity Specification (2022)

Failed Impurities/Degradation Specifications: OOS result was obtained for Any Other Individual Impurity at the 12M room temperature time point.

Class IIModerate

FDAApr 1, 2022Nationwide• Mylan Institutional, Inc. (d.b.a. UDL Laboratories)

Esomeprazole Magnesium Capsules (Mylan) – Impurity Specification Failure (2022)

Failed Impurities/Degradation Specifications: OOS result was obtained for Any Other Individual Impurity at the 12M room temperature time point.

Class IIModerate

FDAApr 1, 2022Nationwide• Mylan Institutional, Inc. (d.b.a. UDL Laboratories)